2 withdrawn, 1 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Withdrawn 2, Completed 1 |
Follow Advanced Solid Neoplasms: new trials by email Literature Review of Advanced Solid Neoplasms trials Research Report on Advanced Solid Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess Mass Balance, Pharmacokinetics (PK), and Metabolism of Orally Administered [14 C]-TAK-659 in Participants With Advanced Solid Tumor and/or Lymphoma Malignancies [14C]-TAK-659, TAK-659 - Advanced Solid Neoplasms, Lymphoma Neoplasms | Phase 1 | Withdrawn | Calithera Biosciences, Inc | 2018-05-10 | 2023-02-08 | |
| A Study to Evaluate the Effect of Food on the Pharmacokinetics (PK) of TAK-659 in Participants With Advanced Solid Tumor TAK-659 - Lymphoma, Malignant, Advanced Solid Neoplasms | Phase 1 | Withdrawn | Calithera Biosciences, Inc | 2018-02-28 | 2023-02-08 | |
| A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors JNJ-64457107 - Advanced Solid Neoplasms | Phase 1 | Completed | Janssen Research & Development, LLC | 95 | 2016-09-21 | 2022-10-06 |
Lymphoma (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
TAK-659 (2) · mitazalimab (1)
Calithera Biosciences, Inc (2) · Janssen Research & Development, LLC (1)
Israel (1) · Spain (1) · United States (1)
2016 (1), 2017 (1)